North America DNA Sequencing Products Market to Reach US$ 5.2 Billion by 2027, Spurred by Growing Preference for Personalized Medicines

September 07, 2020

According to the latest report by IMARC Group, titled "North America DNA Sequencing Products Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the North America DNA sequencing products market reached a value of US$ 2.2 Billion in 2021. DNA sequencing refers to the process of understanding the accurate sequence of the four nucleotide bases, namely guanine, thymine, adenine and cytosine, present within a DNA molecule. It is widely used for mapping out the human genome and for various applied research applications. It is crucial in determining multiple nucleotide variations related to distinctive genetic diseases, thereby aiding in the study of several complex disorders. Apart from this, it is extensively used for numerous research studies and applications, such as genome editing, forensic sciences, agrigenomics, species discovery, DNA recombination, hereditary disease detection, and phylogenetic analysis.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

North America DNA Sequencing Products Market Trends:

The North American market is primarily driven by the growing utilization of DNA sequencing products in in-vitro diagnostics. These diagnostics are used to detect multiple diseases and monitor a person’s overall health for curing and preventing several medical conditions. Since next-generation sequencing tests are usually performed to scan a person’s DNA for detecting genomic variations, this is providing a thrust to the market growth. The growing preference for personalized medicines and targeted therapies among patients is acting as a major growth-inducing factor. DNA sequencing provides information about the genetic basis of several diseases. This aids in the development of precise treatments to affect the pathogens in the body without damaging healthy cells. The market is further driven by the increasing initiatives undertaken by several industry players in the region to facilitate the development of new and affordable technologies. For instance, the National Human Genome Research Institute (NHGRI), a US-based institute and a part of the National Institutes of Health (NIH), offers grants in developing cost-effective DNA sequencing with the use of nanoscale technologies. Numerous companies are also engaging to develop alternative sequencing technologies that offer improved yield, speed and sensitivity, thereby creating a positive outlook for the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 5.2 Billion by 2027, exhibiting a CAGR of 15.4% during 2022-2027.

Market Summary:

  • Based on the product type, the market has been divided into consumables and reagents, and equipments.
  • On the basis of the application, the market has been classified into biomarkers, diagnostics, reproductive health, forensics, personalized medicine and others.
  • Based on the end user, the market has been categorized into academic and government research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others.
  • On the geographical front, the market has been bifurcated into the United States and Canada.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

North America DNA Sequencing Products Market to Reach US$ 5.2 Billion by 2027, Spurred by Growing Preference for Personalized Medicines
Select Licence Type

Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More